Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 976 AL 990

CLSI Validation of Exchangeable Copper Determination in Serum by ICP-MS: A Focus on Alzheimer's Disease and Wilson Disease

Squitti R, Pal A, Ivanova ID, Marianetti M, Rongioletti M.

Biomolecules. 2025 May 29;15(6):788. doi: 10.3390/biom15060788.

Development and Validation of an ICP-MS/MS Method for the Multielemental Analysis of Cerebrospinal Fluid, Examination of Alzheimer's Disease Samples

Pérez-Ramírez R, Cuchillo-Ibáñez I, Sánchez-Romero R, Beltrán-Sanahuja A, Escamilla S, Molina-Gasset R, Zetterberg H, Blennow K, Sáez-Valero J, Todolí-Torró JL.

J Neurochem. 2025 Nov;169(11):e70307. doi: 10.1111/jnc.70307.

Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain-Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease

Dulewicz M, Kac PR, Ortiz FG, Karikari TK, Kulczyńska-Przybik A, Mroczko B, Turton M, Harrison P, Maler M, Oberstein T, Kornhuber J, Hanrieder J, Zetterberg H, Blennow K, Lewczuk P.

J Neurochem. 2025 Dec;169(12):e70313. doi: 10.1111/jnc.70313.

Dual single nucleotide polymorphisms typing of apolipoprotein E gene based on double restriction endonuclease with lambda exonuclease and triple helix molecular switch assistance

Lin G, Liang W, He Q, Wang Y, Yang X.

Biosens Bioelectron. 2025 Jun 15;278:117365. doi: 10.1016/j.bios.2025.117365. Epub 2025 Mar 11.

Extension and external validation of mapping between the Mini-Mental State Examination and the Clinical Dementia Rating scale in patients with Alzheimer's disease

Brogaard NJ, Hahn-Pedersen JH, Gundgaard J, Polavieja P, Bray BD, Chan MS, Hoang M, Trepel D.

Alzheimers Dement. 2025 Jun;21(6):e70163. doi: 10.1002/alz.70163.

Validation of dementia-free status in the iranian brain imaging database using ADNI data: a transition point from middle age to older adulthood

Ghaderi S, Mohammadi S, Fatehi F, Sisakhti M, Batouli SAH; Alzheimer’s Disease Neuroimaging Initiative.

BMC Neurol. 2025 Jul 10;25(1):286. doi: 10.1186/s12883-025-04293-3.

Validation study of the Persian version of behavioral pathology in Alzheimer's Disease Rating scale (BEHAVE-AD) and the empirical BHAVE-AD (E-BEHAVE-AD)

Noroozian M, Vahabi Z, Hooshyari Z, Etesam F, Tarighatnia H.

Appl Neuropsychol Adult. 2025 Mar-Apr;32(2):431-441. doi: 10.1080/23279095.2023.2175680. Epub 2023 Feb 11.

Health App Review Tool (HART): Content validation through expert panel review

Moon S, Best K, Choi YK, Faieta J.

Assist Technol. 2025 Feb 14;37(sup1):S3-S8. doi: 10.1080/10400435.2024.2337857. Epub 2024 Apr 17.

Reproducibility and validity of adapted clinical tests for the assessment of muscle strength in community-dwelling older adults living with Alzheimer's disease

de Oliveira MPB, Calixtre LB, de Castro Cezar NO, Lima-Truax C, Truax BD, de Medeiros Takahashi AC, de Oliveira Sato T, Pelicioni PHS, da Silva Serrão PRM, de Andrade LP.

BMC Geriatr. 2025 Aug 18;25(1):636. doi: 10.1186/s12877-025-06269-x.

Preliminary Validation of the FCD-Q8 Tool in Functional Cognitive Disorder and Early Alzheimer's Disease: A Biomarker-Verified Case-Control Study

García-Roldán E, Almodóvar-Sierra Á, Luque-Tirado A, Marín Cabañas AM, Bernal Sánchez-Arjona M, Franco-Macías E.

Eur J Neurol. 2025 Nov;32(11):e70383. doi: 10.1111/ene.70383.

Clinical validation of new alzheimer disease diagnosis tools based on plasma p-Tau217

Martí-Navia A, Álvarez-Sánchez L, Ferré-González L, López A, Peña-Bautista C, Balaguer Á, Pedrosa N, Vico H, Baquero M, Cháfer-Pericás C.

Sci Rep. 2025 Dec 7;16(1):1472. doi: 10.1038/s41598-025-31613-x.

Hyperspectral retinal imaging to detect Alzheimer's disease in a memory clinic setting

Dallora AL, Alexander J, Palesetti PP, Guenot D, Selvander M, Berglund JS, Behrens A.

Alzheimers Res Ther. 2025 Oct 28;17(1):232. doi: 10.1186/s13195-025-01887-4.

Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study

Guo R, Li D, Li F, Ji L, Liu H, Qiao H, Lv Z, Tang Y, Wang D.

J Alzheimers Dis. 2025 Mar;104(1):52-60. doi: 10.1177/13872877251313819. Epub 2025 Feb 5.

Meta-Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross-Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross-Study Heterogeneity

Hou J, Hess JL, Zhang C, van Rooij JGJ, Hearn GC, Fan CC, Faraone SV, Fennema-Notestine C, Lin SJ, Escott-Price V, Seshadri S; Alzheimer's Disease Neuroimaging Initiative; Holmans P, Tsuang MT, Kremen WS, Gaiteri C, Glatt SJ.

Am J Med Genet B Neuropsychiatr Genet. 2025 Jun;198(4):e33019. doi: 10.1002/ajmg.b.33019. Epub 2024 Dec 16.

Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023

Anschuetz A, Schwab K, Harrington CR, Wischik CM, Riedel G.

J Alzheimers Dis. 2025 Sep;107(2):452-476. doi: 10.1177/13872877251362212. Epub 2025 Sep 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias